COMMUNIQUÉS West-GlobeNewswire

Tetra's Officers and Employees Participate in Private Placement

30/07/2019 - 14:30

ORLEANS, Ontario, July 30, 2019 (GLOBE NEWSWIRE) -- Tetra Bio-Pharma Inc. (“Tetra” or the “Corporation”) is pleased to announce that, after successfully completing a prospectus offering for aggregate gross proceeds of $ [...]

Auris Medical Announces Randomization of First Patient in AM-125 Phase 2 Trial in Acute Vertigo

30/07/2019 - 14:30

Hamilton, Bermuda, July 30, 2019 (GLOBE NEWSWIRE) -- Auris Medical Holding Ltd. (NASDAQ: EARS), a clinical-stage company dedicated to developing therapeutics that address important unmet medical needs in neurotology and [...]

TransMedics Announces Successful Long Distance Retrieval and Transplantation of Donor Lungs from Hawaii Using Organ Care System (OCS™)

30/07/2019 - 14:30

ANDOVER, Mass., July 30, 2019 (GLOBE NEWSWIRE) -- TransMedics Group, Inc. (“TransMedics”) (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, [...]

NewLink Genetics Provides Corporate Update and Reports Second Quarter 2019 Financial Results

30/07/2019 - 14:30

Announces management transition; Charles J. Link Jr, M.D. to retire as CEO and Chairman of the Board AMES, Iowa, July 30, 2019 (GLOBE NEWSWIRE) -- NewLink Genetics Corporation (NASDAQ:NLNK) (“NewLink Genetics” or the “ [...]

Fluidigm Announces 3rd Annual Imaging Mass Cytometry User Group Meeting

30/07/2019 - 14:30

Fluidigm Invites Researchers to the Largest Global Imaging Mass Cytometry Conference in Zurich, Switzerland SOUTH SAN FRANCISCO, Calif., July 30, 2019 (GLOBE NEWSWIRE) -- Fluidigm Corporation (NASDAQ:FLDM), an [...]

LHC Group announces agreement to purchase assets from VNA Home Health of Maryland

30/07/2019 - 14:20

Purchase to include home health and home and community based services in Baltimore LAFAYETTE, La., July 30, 2019 (GLOBE NEWSWIRE) -- LHC Group, Inc. (NASDAQ: LHCG) announced today that it has agreed to purchase a home [...]

Eton Pharmaceuticals to Report Second Quarter 2019 Financial Results on Tuesday, August 6, 2019

30/07/2019 - 14:01

DEER PARK, Ill., July 30, 2019 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc (Nasdaq: ETON), a specialty pharmaceutical company focused on developing and commercializing innovative drug products, today announced that it [...]

Principia Announces Update to Ongoing Phase 2 Clinical Trial in Patients with ITP

30/07/2019 - 14:01

SOUTH SAN FRANCISCO, Calif., July 30, 2019 (GLOBE NEWSWIRE) -- Principia Biopharma Inc. (Nasdaq: PRNB), a late-stage biopharmaceutical company dedicated to bringing transformative oral therapies to patients with [...]

Cambrex to Double Size of Edinburgh Solid Form Screening Facility

30/07/2019 - 14:00

EAST RUTHERFORD, N.J., July 30, 2019 (GLOBE NEWSWIRE) -- Cambrex Corporation (NYSE: CBM), the leading small molecule company providing drug substance, drug product and analytical services across the entire drug [...]

Susan Kenney Certified as a Brain Health Coach by Amen Clinics

30/07/2019 - 14:00

Emergo Recovery Co-Founder and Director of Therapeutic Wellness completes training on the Amen Clinics Method and cultivating brain health through neurobiology and practical neuroscience BARRIE, Ontario, July 30, 2019 ( [...]

Intellia Therapeutics to Present at August Healthcare Investor Conference

30/07/2019 - 14:00

CAMBRIDGE, Mass., July 30, 2019 (GLOBE NEWSWIRE) -- Intellia Therapeutics, Inc. (NASDAQ:NTLA), a leading genome editing company focused on developing curative therapeutics using CRISPR/Cas9 technology both in vivo and [...]

HealthLynked Announces Participation in the 2019 Florida Medical Association Conference and Exhibition in Orlando, Florida

30/07/2019 - 14:00

NAPLES, Fla., July 30, 2019 (GLOBE NEWSWIRE) -- HealthLynked Corp. (OTCQB: HLYK) today announced it will be participating in the Florida Medical Association Annual Meeting in Orlando, Florida, from Friday, August 9 [...]

CytomX Therapeutics to Announce Second Quarter 2019 Financial Results

30/07/2019 - 14:00

-Teleconference Scheduled for August 7, 2019, at 5:00 p.m. ET- SOUTH SAN FRANCISCO, Calif., July 30, 2019 (GLOBE NEWSWIRE) -- CytomX Therapeutics, Inc. (Nasdaq: CTMX), a clinical-stage oncology-focused biopharmaceutical [...]

H-CYTE Bolsters Board of Directors With Appointment of Dr. Atta Behfar to its Board of Directors

30/07/2019 - 14:00

TAMPA, Fla., July 30, 2019 (GLOBE NEWSWIRE) -- H-CYTE Inc. (OTCQB: HCYT) (“H-CYTE” or the “Company”), the owner and operator of innovative medical technology products and services including Lung Health Institute , today [...]

Evelo Biosciences to Host Quarterly Corporate Update Conference Call on Tuesday, August 6th

30/07/2019 - 14:00

CAMBRIDGE, Mass., July 30, 2019 (GLOBE NEWSWIRE) -- Evelo Biosciences, Inc. (Nasdaq: EVLO) (“Evelo”), a biotechnology company developing oral biologics that act on cells in the small intestine with systemic therapeutic [...]

Covetrus Announces Second Quarter 2019 Earnings Release Date and Conference Call Information

30/07/2019 - 14:00

PORTLAND, Maine, July 30, 2019 (GLOBE NEWSWIRE) -- Covetrus (NASDAQ: CVET), a global leader in animal-health technology and services, announced today that it will release second quarter 2019 results the morning of [...]

Beyond Air™ Schedules First Fiscal Quarter 2020 Financial Results Conference Call and Webcast

30/07/2019 - 14:00

Call scheduled for Wednesday, August 14th at 4:30pm Eastern Time GARDEN CITY, N.Y. and REHOVOT, Israel, July 30, 2019 (GLOBE NEWSWIRE) -- Beyond Air, Inc. (NASDAQ: XAIR), a clinical-stage medical device and [...]

Predictive Oncology Subsidiary Helomics Executes Next Phase of Agreement with Interpace to Enhance the Diagnosis of Thyroid Cancer via AI-Driven Models

30/07/2019 - 14:00

Three Most Recent Pittsburgh-Based Development Partnerships Demonstrate Value and Recognition for Helomics’ AI-Driven, Patient Derived “Multi-Omic” Discovery Platform MINNEAPOLIS, July 30, 2019 (GLOBE NEWSWIRE) -- [...]

Capricor Therapeutics to Present Second Quarter 2019 Financial Results and Recent Corporate Update on August 6

30/07/2019 - 14:00

LOS ANGELES, July 30, 2019 (GLOBE NEWSWIRE) -- Capricor Therapeutics (NASDAQ: CAPR), a clinical-stage biotechnology company focused on the development of first-in-class biological therapeutics for the treatment of [...]